GlassScriptPhysician profile
Robert Charles Greenberg
NPI 1710970827
$2,171.66
in general payments reported to CMS, 2019-2025
14 companies · $1,149 in 2025
The $1,149 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $14.71 · 2021: $30.66 · 2022: $43.42 · 2023: $126 · 2024: $328 · 2025: $1,149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,055 · Travel and Lodging: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,055.14 |
| Travel and Lodging | $548.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Music City Medical Technologies, LLC | $747.48 | 2024-2025 | |
| Stryker Corporation | $713.40 | 2019-2025 | Makoplasty, Aequalis Ascend Flex, Triathlon |
| Arthrex, INC. | $227.66 | 2024 | |
| Alpha Orthopedic Systems | $107.73 | 2023 | |
| Zimmer Biomet Holdings, INC. | $95.87 | 2019 | |
| Smith+Nephew, INC. | $53.44 | 2019 | |
| Orthofix Medical, INC. | $51.29 | 2020-2025 | Physio-Stim |
| Depuy Synthes Sales INC. | $46.42 | 2019 | |
| Solventum Corporation | $37.33 | 2025 | Prevena, V.A.C.Instill, Activ.A.C. |
| Axogen | $27.33 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $24.54 | 2025 | |
| Ethicon US, LLC | $16.09 | 2022 | |
| Bioventus LLC | $13.08 | 2019 | |
| Skeletal Dynamics INC | $10.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Greenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.